Pfizer Launches 2016 Annual Review
Today, Pfizer launched its 2016 Annual Review, which provides an in-depth look at how the company is working to accelerate patient impact. The report provides an overview of the company’s financial, social and environmental performance throughout last year.
In 2016, Pfizer made significant progress in the execution of our strategy and the achievement of our mission to become the premier biopharmaceutical company in the industry by the end of this decade. It was a strong year with substantial contributions across every part of Pfizer’s organization. Highlights throughout the year include:
-
Sharpened focus on areas of biomedical R&D that will give us the best promise of success
-
Collaboration to enhance the medicines, vaccines and therapies in our pipeline
-
Solid execution to drive strong financial performance on behalf of our shareholders
-
Work to improve global health by making our therapies more accessible
-
A culture that is centered upon accountability, confidence and resiliency
Learn more about the ways we’re helping individuals everywhere live healthier lives at www.pfizer.com/annual.
